These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8722379)

  • 21. Molecular mimicry between Helicobacter pylori and the host.
    Appelmelk BJ; Negrini R; Moran AP; Kuipers EJ
    Trends Microbiol; 1997 Feb; 5(2):70-3. PubMed ID: 9108933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial factors that mediate colonization of the stomach and virulence of Helicobacter pylori.
    Clyne M; Dolan B; Reeves EP
    FEMS Microbiol Lett; 2007 Mar; 268(2):135-43. PubMed ID: 17313591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of a clinical isolate of urease-negative Helicobacter pylori and its ability to induce gastric ulcers in Mongolian gerbils.
    Mine T; Muraoka H; Saika T; Kobayashi I
    Helicobacter; 2005 Apr; 10(2):125-31. PubMed ID: 15810942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori vacuolating cytotoxin, VacA.
    Hirayama T; Wada A; Yahiro K; Kimura M; Kimura T
    Jpn J Infect Dis; 2002 Feb; 55(1):1-5. PubMed ID: 11971154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lewis epitopes on outer membrane vesicles of relevance to Helicobacter pylori pathogenesis.
    Hynes SO; Keenan JI; Ferris JA; Annuk H; Moran AP
    Helicobacter; 2005 Apr; 10(2):146-56. PubMed ID: 15810946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure, function and localization of Helicobacter pylori urease.
    Dunn BE; Phadnis SH
    Yale J Biol Med; 1998; 71(2):63-73. PubMed ID: 10378351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
    Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
    Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the putative virulence markers (cagA and vacA ) of Helicobacter pylori in peptic ulcer disease.
    Salih BA
    Saudi Med J; 2004 Jul; 25(7):830-6. PubMed ID: 15235683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The functional status of the Helicobacter pylori sabB adhesin gene as a putative marker for disease outcome.
    de Jonge R; Pot RG; Loffeld RJ; van Vliet AH; Kuipers EJ; Kusters JG
    Helicobacter; 2004 Apr; 9(2):158-64. PubMed ID: 15068418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of endotoxin in infection: Helicobacter pylori and Campylobacter jejuni.
    Moran AP
    Subcell Biochem; 2010; 53():209-40. PubMed ID: 20593269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenic mechanisms of Helicobacter pylori.
    Dunn BE
    Gastroenterol Clin North Am; 1993 Mar; 22(1):43-57. PubMed ID: 8449569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of gastroduodenal disease phenotype with ABO blood group and Helicobacter pylori virulence-specific serotypes.
    Sharara AI; Abdul-Baki H; ElHajj I; Kreidieh N; Kfoury Baz EM
    Dig Liver Dis; 2006 Nov; 38(11):829-33. PubMed ID: 16931196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between expression of HSP60, urease activity, production of vacuolating toxin, and adherence activity of Helicobacter pylori.
    Yamaguchi H; Osaki T; Taguchi H; Hanawa T; Yamamoto T; Kamiya S
    J Gastroenterol; 1998; 33 Suppl 10():6-9. PubMed ID: 9840008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM
    Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are Helicobacter pylori differences important in the development of Helicobacter pylori-related diseases?
    Figura N
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):367-74. PubMed ID: 9476194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Helicobacter pylori CagA antigen antibodies].
    Havlasová J; Bures J; Rejchrt S; Voxová B; Krejsek J
    Cas Lek Cesk; 1998 Jun; 137(13):404-9. PubMed ID: 9748734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocyte and macrophage killing of helicobacter pylori: relationship to bacterial virulence factors.
    Borlace GN; Butler RN; Brooks DA
    Helicobacter; 2008 Oct; 13(5):380-7. PubMed ID: 19250513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of dietary anti-urease immunoglobulin Y on Helicobacter pylori infection in Mongolian gerbils.
    Nomura S; Suzuki H; Masaoka T; Kurabayashi K; Ishii H; Kitajima M; Nomoto K; Hibi T
    Helicobacter; 2005 Feb; 10(1):43-52. PubMed ID: 15691314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imunosuppression by a corticosteroid fails to exacerbate Helicobacter pylori infection in a mouse model of gastric colonization.
    Conlan JW; KuoLee R; Webb A; Perry MB
    Can J Microbiol; 1999 Nov; 45(11):975-80. PubMed ID: 10588046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanoidin, a food protein-derived advanced maillard reaction product, suppresses Helicobacter pylori in vitro and in vivo.
    Hiramoto S; Itoh K; Shizuuchi S; Kawachi Y; Morishita Y; Nagase M; Suzuki Y; Nobuta Y; Sudou Y; Nakamura O; Kagaya I; Goshima H; Kodama Y; Icatro FC; Koizumi W; Saigenji K; Miura S; Sugiyama T; Kimura N
    Helicobacter; 2004 Oct; 9(5):429-35. PubMed ID: 15361082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.